The success of Viagra initially sparked a surge for pharma, however recent shifts present a complicated outlook for investors. Generic competitors are eating into revenue, and persistent patent challenges add further https://nelsonyxvt651528.blogrenanda.com/48081975/sildenafil-and-big-pharma-a-risky-investment